Search by Drug Name or NDC

NDC 31722-0815-32 LACOSAMIDE 200 mg/1 Details

LACOSAMIDE 200 mg/1

LACOSAMIDE is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Camber Pharmaceuticals, Inc.. The primary component is LACOSAMIDE.

MedlinePlus Drug Summary

Lacosamide is used to control partial onset seizures (seizures that involve only one part of the brain) in adults and children 1 month of age and older. Lacosamide is also used in combination with other medications to control primary generalized tonic-clonic seizures (formerly known as a grand mal seizure; seizure that involves the entire body) in adults and children 4 years of age and older. Lacosamide is in a class of medications called anticonvulsants. It works by decreasing abnormal electrical activity in the brain.

Related Packages: 31722-0815-32
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Lacosamide

Product Information

NDC	31722-0815
Product ID	31722-815_ef3bd810-b27b-6ac2-e053-2995a90ac997
Associated GPIs	72600036000350
GCN Sequence Number	064435
GCN Sequence Number Description	lacosamide TABLET 200 MG ORAL
HIC3	H4B
HIC3 Description	ANTICONVULSANTS
GCN	14342
HICL Sequence Number	035872
HICL Sequence Number Description	LACOSAMIDE
Brand/Generic	Generic
Proprietary Name	LACOSAMIDE
Proprietary Name Suffix	n/a
Non-Proprietary Name	LACOSAMIDE
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, FILM COATED
Route	ORAL
Active Ingredient Strength	200
Active Ingredient Units	mg/1
Substance Name	LACOSAMIDE
Labeler Name	Camber Pharmaceuticals, Inc.
Pharmaceutical Class	Decreased Central Nervous System Disorganized Electrical Activity [PE]
DEA Schedule	CV
Marketing Category	ANDA
Application Number	ANDA204787
Listing Certified Through	2024-12-31

Package

NDC 31722-0815-32 (31722081532)

Pricing Information	N/A
NDC Package Code	31722-815-32
Billing NDC	31722081532
Package	100 TABLET, FILM COATED in 1 BLISTER PACK (31722-815-32)
Marketing Start Date	2022-03-17
NDC Exclude Flag	N